Sarah Cannon/Colorado Blood Cancer Institute — Denver, Colorado

Sarah Cannon/Colorado Blood Cancer Institute is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon/Colorado Blood Cancer Institute has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Multiple Myeloma.

Sponsors: Allogene Therapeutics.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon/Colorado Blood Cancer Institute?

Sarah Cannon/Colorado Blood Cancer Institute has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon/Colorado Blood Cancer Institute conducted?

Sarah Cannon/Colorado Blood Cancer Institute has 2 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Multiple Myeloma.

Is Sarah Cannon/Colorado Blood Cancer Institute accredited by Crixeo Health?

Sarah Cannon/Colorado Blood Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon/Colorado Blood Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.